[{"Assets_0_Q2_USD":"47809000000.0","CIK":"59478","CommonStockDividendsPerShareDeclared_1_Q2_USD":"1.7","CommonStockDividendsPerShareDeclared_2_Q2_USD":"1.7","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.53","EarningsPerShareBasic_2_Q2_USD":"3.02","EarningsPerShareDiluted_1_Q2_USD":"1.53","EarningsPerShareDiluted_2_Q2_USD":"3.01","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q2_USD":"219100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"3472900000.0","NetIncomeLoss_1_Q2_USD":"1390200000.0","NetIncomeLoss_2_Q2_USD":"2745500000.0","OfficialName":"Eli Lilly and Company Common Stock","ProfitLoss_2_Q2_USD":"2745500000.0","RevenuesConverted_1_Q2_USD":"6740100000.0","RevenuesConverted_2_Q2_USD":"13545700000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"6663500000.0","StockholdersEquity_0_Q2_USD":"6444400000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"910400000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"911600000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"907300000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"908200000.0","filed":"20210803","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"ELI LILLY & CO","period":"20210630","qtrs":"0","uom":"USD"}]